Logo SEFAC
Farm Comunitarios. 2022 Apr 26;14(2):40-45. doi: 10.33620/FC.2173-9218.(2022/Vol14).002.07

Drug-induced blood dyscrasias with onset of respiratory symptoms

Rodríguez Chamorro MA1, García Jiménez E2, Rodríguez Pérez A3, Pérez Merino EM4
1. Doctor en Farmacia. Experto universitario en Seguimiento Farmacoterapéutico por la Universidad de Granada. Máster en Ciencia y Tecnología de la carne por la Universidad de Extremadura. Farmacéutico comunitario en Talavera de la Reina (Toledo). 2. Doctor en Farmacia. Experto universitario en Seguimiento Farmacoterapéutico por la Universidad de Granada. Profesor colaborador de la Cátedra de Atención Farmacéutica. Facultad Farmacia. Universidad San Pablo CEU. Madrid. Farmacéutico comunitario en Granada. 3. Graduada en Farmacia por la Universidad de Salamanca. Farmacéutica comunitaria en Talavera de la Reina (Toledo). 4. Doctora en Veterinaria. Profesora asociada de la Cátedra de Cirugía. Facultad de Veterinaria. Universidad de Extremadura.
Rodríguez MA, García E, Rodríguez A, Pérez EM. Drug-induced blood dyscrasias with onset of respiratory symptoms. Farm Comunitarios. 2022 Apr 26;14(2):40-45. doi: 10.33620/FC.2173-9218.(2022/Vol14).002.07
Abstract : 
A patient, diagnosed with ulcerative colitis and rheumatoid arthritis and treated with mesalazine and hydroxychloroquine, presented with symptoms of catarrh similar to those of COVID-19. The pharmacotherapeutic monitoring service (PMS) provided to the patient allowed us to associate these symptoms with a side effect of the drug taken by the patient, i.e., blood dyscrasias. The intervention, carried out to inform the doctor while the patient was symptomatic, allowed the HCP to modify the treatment by reducing the doses of the drugs used until the condition was under control.
Keywords : 
Pharmacotherapy follow-up, agranulocytosis, blood dyscrasias

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/

Share

-

Related contents

Published by

Manual for authors

Journal Information